How does TFC compare to Wuhan Wansheng Biotechnology on documentation quality?

Conditions: TFC · Wuhan Wansheng Biotechnology.

I would like the axes of comparison first and the recommendation second.

I have tried the first option and it works; the question is whether the second is better rather than merely different.

Under what conditions does the answer flip?

Put another way, this is the question where methodology matters more than the conclusion.

Content is the more discriminating measurement than purity for supplier comparison, because purity clusters tightly among competent suppliers and content does not.

Publish the method with the result. A comparison without the laboratory named and the submission dates given is not reproducible by anyone.

Inter-laboratory spread on identical peptide material is routinely half a per cent to a per cent by RP-HPLC, which is the noise floor for any cross-laboratory comparison.

One laboratory, one method, one submission. Otherwise it is not a comparison.

On the detail: a single member running three suppliers on one method is worth more than thirty members running one supplier each.

Sample size matters. One order each is an anecdote about six vials; three orders each over a year is the beginning of a comparison.

To compare properly: order the same compound at the same nominal strength from each supplier, submit all samples to the same laboratory in the same submission if possible, and ask for the same test set on each.

Compare content, not purity. Purity clusters and content does not.

The short version: same compound, same laboratory, same method, ideally same week — otherwise you are comparing laboratories rather than suppliers.

Lead time and lane behaviour are supplier properties too and are easier to compare than analytical ones, because they need no laboratory at all.

Nothing here is medical advice, and research-use compounds are not approved for human use.

Price per milligram of measured peptide, not per milligram of label claim.

edited 25 Mar 2026 by pk_curve — clarified the distinction between purity and content

The relevant point is that two competent laboratories disagree by half a per cent on identical material, which is larger than most of the differences people argue about.

Cost per milligram of actual peptide is the honest price comparison, which means dividing by measured content rather than by label claim.

The ratings on this site are a community opinion average on a ten-point scale and are not reconciled with any other community's figures.

Comparisons drawn from different laboratories at different times are weaker evidence than most people treat them as.

Name the laboratory and the dates or the comparison cannot be reproduced.